Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Contrib Nephrol ; 187: 9-23, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26881939

RESUMEN

Acute kidney injury (AKI) is a condition associated with significant morbidity and mortality. The incidence of AKI is increasing due to predisposing factors (sepsis, nephrotoxins, and hypotension). This review will focus on the risk stratification of patients vulnerable to developing AKI in whom the timing of the insult is known (e.g., cardiac surgery, contrast exposure) as well as the clinical context in which the risk intensifies. The review will also focus on preventive measures and different pharmacological agents for preventing AKI. Clinical trials of pharmacological agents for the prevention of AKI are challenging. While many compounds are promising in preclinical testing, only a few compounds have been tested, and none has shown consistent results in clinical trials. This is in part due to the lack of large and well-designed trials. With well-designed clinical trials, the use of novel biomarkers and innovative therapeutic strategies, we are on the verge of improving outcomes in the prevention of AKI.


Asunto(s)
Lesión Renal Aguda/prevención & control , Acetilcisteína/uso terapéutico , Lesión Renal Aguda/etiología , Ensayos Clínicos como Asunto , Medios de Contraste/efectos adversos , Corazón Auxiliar/efectos adversos , Humanos , Medición de Riesgo , Reemplazo de la Válvula Aórtica Transcatéter/efectos adversos
2.
Ann Thorac Surg ; 101(2): 606-12; discussion 612, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26680309

RESUMEN

BACKGROUND: Renal failure remains a major source of morbidity after cardiac surgery. Whereas the relationship between poor renal function and worse cardiac surgical outcomes is well established, the ability to predict the impact of preoperative renal insufficiency on hospital costs and health care resource utilization remains unknown. METHODS: Patient records from a statewide The Society for Thoracic Surgeons (STS) database linked with estimated cost data were evaluated for isolated coronary artery bypass graft (CABG) operations (2000 to 2012). Patients with documented preoperative renal failure/dialysis were excluded. Preoperative renal function was determined using calculated creatinine clearance (CrCl). Multivariable regression analyses utilizing restricted cubic splines evaluated the continuous relationship between CrCl and risk-adjusted outcomes. RESULTS: A total of 46,577 isolated CABG operations were evaluated with a median STS predicted risk of mortality score of 1.2% (interquartile range, 0.7% to 2.4%), including 9% off-pump CABG. Median CrCl was 85 mL/min (range, 2 to 120 mL/min), and median total cost was $25,011. After adjustment for preoperative risk factors, worsening CrCl (declining renal function) was highly associated with greater total costs of hospitalization (coefficient = -122, p < 0.001) and postoperative length of stay (coefficient = -0.03, p < 0.001). Furthermore, predicted total costs were incrementally increased by 10%, 20%, and 30% with worsening of CrCl from 80 mL/min to 60, 40, and 20 mL/min. As expected, decreasing CrCl was also associated with an increased risk-adjusted likelihood for hemodialysis and mortality (both p < 0.001). CONCLUSIONS: Preoperative renal function is highly associated with the cost of CABG. Assessment of renal function may be used to preoperatively predict cost and resource utilization. Optimizing renal function preoperatively has the potential to improve patient quality and costs by approximately 6% ($1,250) for every 10 mL/min improvement in creatinine clearance.


Asunto(s)
Puente de Arteria Coronaria/economía , Enfermedad de la Arteria Coronaria/cirugía , Costos de Hospital/tendencias , Tiempo de Internación/tendencias , Complicaciones Posoperatorias/economía , Medición de Riesgo , Anciano , Enfermedad de la Arteria Coronaria/economía , Enfermedad de la Arteria Coronaria/mortalidad , Femenino , Estudios de Seguimiento , Mortalidad Hospitalaria/tendencias , Humanos , Tiempo de Internación/economía , Masculino , Morbilidad/tendencias , Complicaciones Posoperatorias/epidemiología , Periodo Preoperatorio , Pronóstico , Estudios Retrospectivos , Factores de Riesgo , Estados Unidos/epidemiología
3.
Nephron ; 131(3): 185-90, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26524288

RESUMEN

BACKGROUND: Acute kidney injury (AKI) is a frequent complication of hospitalized patients and is associated with poor outcomes. Hospitalized patients with AKI may need prolonged dialysis, necessitating post-hospitalization dialysis (PHD-AKI). Scarce information is available to stratify the risks and predict outcomes. This study aims to assess outcomes and identify predictors of outcomes of PHD-AKI within 90 days. METHODS: All adult AKI patients initiating hemodialysis (HD) at the University of Virginia (UVA) between June 1, 2012, and September 30, 2013 were retrospectively studied. PHD-AKI patients continued treatment at a specifically designated unit. They were followed until an outcome (end-stage renal disease [ESRD], death or dialysis-independence) was achieved. RESULTS: During the study period, 108 patients required outpatient dialysis out of 365 AKI patients initiating in-patient HD at UVA. An additional 11 patients who developed dialysis-requiring AKI at referring hospitals but underwent HD at our unit were included for a total of 119 patients studied. ESRD was declared in 48.7%, while 9.2% expired and 42.0% achieved dialysis independence. Congestive heart failure, baseline renal function and a prior episode of AKI within the preceding 6 months were statistically significant predictors of renal outcomes. CONCLUSION: Dialysis independence of PHD-AKI patients is not uncommon. Certain clinical parameters may help predict renal outcome. Identifying predictors of renal recovery will guide further interventions, especially with the Centers for Medicare and Medicaid Services soon to allow AKI patients to be dialyzed at outpatient ESRD facilities. Ongoing biomarkers research may add further knowledge for optimum diagnosis and prognosis of AKI.


Asunto(s)
Lesión Renal Aguda/terapia , Diálisis Renal , Adulto , Anciano , Anciano de 80 o más Años , Cardiomiopatía Dilatada/etiología , Comorbilidad , Creatinina/sangre , Femenino , Humanos , Fallo Renal Crónico/etiología , Pruebas de Función Renal , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Pronóstico , Estudios Retrospectivos , Factores de Riesgo , Resultado del Tratamiento , Urea/sangre , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA